Control of CD4 gene expression: Connecting signals to outcomes in T cell development

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 7, 1999, Pages 785-803

  Sarafova, S D ^a   Siu, G ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

CD4; Development; Gene expression; Silencer; T cell

Indexed keywords

CD4 ANTIGEN;

ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; PROMOTER REGION; REGULATOR GENE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; CELL DIFFERENTIATION; GENE EXPRESSION; GENES, REGULATOR; MICE; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES;

EID: 0033159461     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000700001     Document Type: Article

References (60)

1. Fowlkes BJ & Pardoll D (1989). Molecular and cellular events of T cell development. Advances in Immunology, 44: 207-264.
2. Wu L, Scollay R, Egerton M, Pearse M, Spangrude GJ & Shortman K (1991). CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature, 349: 71-74.
3. von Boehmer H (1988). The developmental biology of T lymphocytes. Annual Review of Immunology, 6: 309-326.
4. + lineage of T cells in mice treated neonatally with anti-la correlates with absence of intrathymic I-A bearing antigen-presenting cell function. Journal of Experimental Medicine, 161: 1029-1047.
5. Berg LJ, Pullen AM, Groth BFDS, Mathis D, Benoist C & Davis MM (1989). Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell, 58: 1035-1046.
6. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C & Mathis D (1991). Mice lacking MHC class II molecules. Cell, 66: 1051-1066.
7. Grusby MJ, Johnson RS, Papaionnou VE & Glimcher LH (1991). Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science, 253: 1417-1420.
8. Perlmutter RM (1993). In vivo dissection of lymphocyte signaling pathways. Clinical Immunology and Immunopathology, 67: S44-S49.
9. - cell cDNAs by subtraction cloning. Molecular Biology of the Cell, 3: 761-773.
10. Prendergast JA, Helgason CD & Bleackley RC (1992). Quantitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. Pattern of expression is dependent on the nature of the stimulus. Journal of Biological Chemistry, 267: 5090-5095.
11. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H & Golstein P (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science, 265: 528-530.
12. Siu G, Wurster AL, Duncan DD, Soliman TM & Hedrick SM (1994). A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO Journal, 13: 3570-3579.
13. Siu G, Wurster AL, Lipsick JS & Hedrick SM (1992). Expression of the CD4 gene requires a Myb transcription factor. Molecular and Cellular Biology, 12: 1592-1604.
14. Salmon P, Giovane A, Wasylyk B & Klatzmann D (1993). Characterization of the human CD4 gene promoter: Transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins. Proceedings of the National Academy of Sciences, USA, 90: 7739-7743.
15. Sawada S & Littman DR (1991). Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene. Molecular and Cellular Biology, 11: 5506-5515.
16. Wurster AL, Siu G, Leiden J & Hedrick SM (1994). Elf-1 binds to a critical element in a second CD4 enhancer. Molecular and Cellular Biology, 14: 6452-6463.
17. Sands JF & Nikolic-Zugic J (1992). T-cell-specific protein-DNA interactions occurring at the CD4 locus: identification of possible transcriptional control elements of the murine CD4 gene. International Immunology, 4: 1183-1194.
18. Sawada S, Scarborough JD, Killeen N & Littman DR (1994). A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell, 77: 917-929.
19. Donda A, Schulz M, Burki K, De Libero G & Uematsu Y (1996). Identification and characterization of a human CD4 silencer. European Journal of Immunology, 26: 493-500.
20. + T cells and in macrophages of transgenic mice. Molecular and Cellular Biology, 14: 1084-1094.
21. Duncan DD, Stupakoff A, Hedrick SM, Marcu KB & Siu G (1995). A Myc-associated zinc-finger protein (MAZ) binding site is one of four important functional regions in the CD4 promoter. Molecular and Cellular Biology, 15: 3179-3186.
22. Nakayama K, Yamamoto R, Ishii S & Nakauchi H (1993). Binding of c-Myb to the core sequence of the CD4 promoter. International Immunology, 5: 817-824.
23. Sarafova SD & Siu G (1999). A potential role for Elf-1 in CD4 promoter function. Journal of Biological Chemistry (in press).
24. Adlam M, Duncan DD, Ng DK & Siu G (1997). Positive selection induces CD4 promoter and enhancer function. International Immunology, 9: 877-887.
25. Salmon P, Boyer O, Lores P, Jami J & Klatzmann D (1996). Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes. Journal of Immunology, 156: 1873-1879.
26. Uematsu Y, Donda A & De Libero G (1997). Thymocytes control the CD4 gene differently from mature T lymphocytes. International Immunology, 9: 179-187.
27. Bendelac A, Matzinger P, Seder RA, Paul WE & Schwartz RH (1992). Activation events during thymic selection. Journal of Experimental Medicine, 175: 731-742.
28. Sawada S & Littman DR (1993). A heterodimer of HEB and an E12-related protein interact with the CD4 enhancer and regulate its activity in T-cell lines. Molecular and Cell Biology, 13: 5620-5628.
29. Bain G, Engel I, Maandag EC, te Reile HPJ, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D & Murre C (1997). E2A deficiency leads to abnormalities in αß T-cell development and to rapid development of T-cell lymphomas. Molecular and Cellular Biology, 17: 4782-4791.
30. Yan W, Young AZ, Soares VC, Kelley R, Benezra R & Zhuang Y (1997). High incidence of T-cell tumors in E2A-null mice and E2A/ld1 double-knockout mice. Molecular and Cellular Biology, 17: 7317-7327.
31. Duncan DD, Adlam M & Siu G (1996). Asymmetric redundancy in CD4 silencer function. Immunity, 4: 301-311.
32. Kim HK & Siu G (1998). The Notch pathway intermediate HES-1 silences CD4 gene expression. Molecular and Cellular Biology, 18: 7166-7175.
33. Robey E, Chang D, Itano A, Cado D, Alexander H, Lane D, Weinmaster G & Salmon P (1996). An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell, 87: 483-492.
34. Allen RD, Bender TP & Siu G (1999). cMyb is essential for early T cell development. Genes and Development (in press).
35. Kim WWS & Siu G (1999). Subclass-specific nuclear localization of a novel CD4 silencer binding factor. Molecular and Cellular Biology (in press).
36. Shore D (1995). Telomere position effects and transcriptional silencing in the yeast Saccharomyces cerevisiae. In: Blackburn EH & Greider CW (Editors), Telomeres Plainview. Cold Spring Harbor Press, New York.
37. Lipsick JS (1996). One billion years of Myb. Oncogene, 13: 223-235.
38. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R & Nakanishi S (1992). Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and enhancer of split. Genes and Development, 6: 2620-2634.
39. Ishibashi M, Ang SL, Shiota K, Nakanishi S, Kageyama R & Guillemot F (1995). Targeted disruption of mammalian hairy and enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes and Development, 9: 3136-3148.
40. Bruniquel D, Borie N & Triebel F (1998). Genomic organization of the human LAG-3/CD4 locus. Immunogenetics, 47: 96-98.
41. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ & Carbone FR (1994). T cell receptor antagonist peptides induce positive selection. Cell, 76: 17-27.
42. Henderson AJ & Calame KL (1995). Lessons in transcriptional regulation learned from studies on immunoglobulin genes. Critical Reviews in Eukaryotic Gene Expression, 5: 255-280.
43. Johnson AD (1995). Molecular mechanisms of cell-type determination in budding yeast. Current Opinion Genetics and Development, 5: 552-558.
44. Komachi K, Redd MJ & Johnson AD (1994). The WD repeats of Tup1 interact with the homeo domain protein alpha 2. Genes and Development, 8: 2857-2867.
45. Bruhn L & Sprague Jr GF (1994). MCM1 point mutants deficient in expression of alpha-specific genes: residues important for interaction with alpha 1. Molecular and Cellular Biology, 14: 2534-2544.
46. Primig M, Winkler H & Ammerer G (1991). The DNA binding and oligomerization domain of MCM1 is sufficient for its interaction with other regulatory proteins. EMBO Journal, 10: 4209-4218.
47. Kirkman-Correia C, Stroke IL & Fields S (1993). Functional domains of the yeast STE12 protein, a pheromone-responsive transcriptional activator. Molecular and Cellular Biology, 13: 3765-3772.
48. Yuan YO, Stroke IL & Fields S (1993). Coupling of cell identity to signal response in yeast: interaction between the alpha 1 and STE12 proteins. Genes and Development, 7: 1584-1597.
49. Vershon AK, Jin Y & Johnson AD (1995). A homeo domain protein lacking specific side chains of helix 3 can still bind DNA and direct transcriptional repression. Genes and Development, 9: 182-192.
50. Mead J, Zhong H, Acton TB & Vershon AK (1996). The yeast alpha2 and Mcm1 proteins interact through a region similar to a motif found in homeodomain proteins of higher eukaryotes. Molecular and Cellular Biology, 16: 2135-2143.
51. Zhong H & Vershon AK (1997). The yeast homeodomain protein MATalpha2 shows extended DNA binding specificity in complex with Mcm1. Journal of Biological Chemistry, 272: 8402-8409.
52. Murre C, McCaw PS & Baltimore D (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding-daughterless, MyoD, and myc proteins. Cell, 56: 777-783.
53. Bossone SA, Asselin C, Patel AJ & Marcu KB (1992). MAZ, a zinc finger, binds to a c-myc and C2 gene sequences regulating transcriptional initiation and termination. Proceedings of the National Academy of Sciences, USA, 89: 7452-7456.
54. Bassuk AG & Leiden JM (1997). The role of Ets transcription factors in the development and function of the mammalian immune system. Advances in Immunology, 64: 65-104.
55. Akazawa C, Sasai Y, Nakanishi S & Kageyama R (1992). Molecular characterization of a rat negative regulator with a basic helix-loop-helix structure predominantly expressed in the developing nervous system. Journal of Biological Chemistry, 267: 21879-21885.
56. Jacobson EM, Li P, Leon-del-Rio A, Rosenfeld MG & Aggarwal AK (1997). Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes and Development, 11: 198-212.
57. Bronowski J (1973). The Ascent of Man. Little, Brown & Company, Boston/Toronto.
58. Bienz M & Muller J (1995). Transcriptional silencing of homeotic genes in Drosophila. Bioessays, 17: 775-784.
59. Ansari-Lari MA, Muzny DM, Lu J, Lu F, Lilley CE, Spanos S, Malley T & Gibbs RA (1996). A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13. Genome Research, 6: 314-326.
60. Vyas P, Vickers MA, Simmons DL, Ayyub H, Craddock CF & Higgs DR (1992). Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin. Cell, 69: 781-793.